Login Register Cart 0
Generic placeholder image

Current Psychopharmacology

Editor-in-Chief

ISSN (Print): 2211-5560
ISSN (Online): 2211-5579

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Have We Placed the Cart Before the Horse by Using Alpha-2A Agonists to Treat Rejection Sensitivity Dysphoria in ADHD?

Author(s): William W. Dodson and Edward Justin Modestino*

Volume 12, 2024

Published on: 05 April, 2024

Article ID: e050424228696 Pages: 3

DOI: 10.2174/0122115560297397240404071044

Open Access Journals Promotions 2
[1]
Reimherr FW, Roesler M, Marchant BK, et al. Types of adult attention deficit/hyperactivity disorder: A replication analysis. J Clin Psychol 2002; 81(2): e1-7.
[2]
Wolraich ML, Chan E, Froehlich T, et al. ADHD diagnosis and treatment guidelines: A historical perspective. Pediatrics 2019; 144(4): e20191682.
[3]
Diagnostic and Statistical Manual of Mental Disorders. (3rd ed.), Washington, DC, USA: American Psychiatric Association 1980.
[4]
Kooij JJS, Bijlenga D, Salerno L, et al. Updated European consensus statement on diagnosis and treatment of adult ADHD. Eur Psychiatry 2019; 56: 14-34.
[5]
Sibley M, Childress A. Why we need US guidelines for adults with ADHD. 2022. Available from: https://ibcces.org/learning/why-we-need-u-s-guidelines-for-adults-with-adhd/
[6]
Stähle H. A historical perspective: Development of clonidine. Baillieres Clin Anaesthesiol 2000; 14: 237-46.
[7]
Cornish LA. Guanfacine hydrochloride: A centrally acting antihypertensive agent. Clin Pharm 1988; 7(3): 187-97.
[PMID: 3281788]
[8]
Groom MJ, Cortese S. Current pharmacological treatments for ADHD. Curr Top Behav Neurosci 2022; 57: 19-50.
[http://dx.doi.org/10.1007/7854_2022_330] [PMID: 35507282]
[9]
Drug approval package.. Intuniv (guanfacine) NDA #022037. 2010. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022037_intuniv_toc.cfm
[10]
Fiks AG, Mayne SL, Song L, et al. Changing patterns of alpha agonist medication use in children and adolescents 2009-2011. J Child Adolesc Psychopharmacol 2015; 25(4): 362-7.
[http://dx.doi.org/10.1089/cap.2014.0122] [PMID: 25919708]
[11]
Neuchat EE, Bocklud BE, Kingsley K, et al. The role of alpha-2 agonists for attention deficit hyperactivity disorder in children: A review. Neurol Int 2023; 15(2): 697-707.
[http://dx.doi.org/10.3390/neurolint15020043] [PMID: 37218982]

Rights & Permissions Print Cite
Article Metrics
19
2
Wayfinder Image
Open Access Journals Promotions
© 2024 Bentham Science Publishers | Privacy Policy